Results 1 to 10 of about 25,973 (244)

Virulence Factors in Coagulase-Negative Staphylococci [PDF]

Pathogens, 2021
Coagulase-negative staphylococci (CoNS) have emerged as major pathogens in healthcare-associated facilities, being S. epidermidis, S. haemolyticus and, more recently, S. lugdunensis, the most clinically relevant species.
Angela França, Vânia Gaio, Nathalie Lopes, Luís D. R. Melo   +3 more
doaj   +4 more sources

Lysogeny In Coagulase-Negative Staphylococci [PDF]

Journal of Medical Microbiology, 1971
Summary Lysogenicity in coagulase-negative staphylococci was tested by incubating the strains in the presence of Mitomycin C. Among 173 strains examined, 45 were found to release phage. Twenty-eight of these phages were obtained from 90 strains belonging to Staphylococcus epidermidis biotype 1 (Baird-Parker, 1965).
J. Verhoef, C. P. A. van Boven, K. Winkler   +2 more
openalex   +4 more sources

Ribotyping of coagulase-negative staphylococci [PDF]

Journal of Medical Microbiology, 1992
The discriminative capacity of ribotyping was initially assessed without knowledge of results obtained for the same isolates by use of more established typing methods. Forty-eight isolates of coagulase-negative staphylococci (CNS) from peritoneal fluids were studied.
B Cookson, Paul Stapleton, H. Ludlam
openalex   +4 more sources

Exploring the Biofilm Formation Capacity in S. pseudintermedius and Coagulase-Negative Staphylococci Species. [PDF]

Pathogens, 2022
The ability of biofilm formation seems to play an important role in the virulence of staphylococci. However, studies reporting biofilm formation of coagulase-negative staphylococci isolated from animals are still very scarce.
Silva V, Correia E, Pereira JE, González-Machado C, Capita R, Alonso-Calleja C, Igrejas G, Poeta P.   +7 more
europepmc   +2 more sources

Coagulase-Negative Staphylococci [PDF]

Clinical Microbiology Reviews, 2014
SUMMARYThe definition of the heterogeneous group of coagulase-negative staphylococci (CoNS) is still based on diagnostic procedures that fulfill the clinical need to differentiate betweenStaphylococcus aureusand those staphylococci classified historically as being less or nonpathogenic.
Karsten Becker
exaly   +5 more sources

Mupirocin resistance in coagulase-negative staphylococci [PDF]

Journal of Medical Microbiology, 1993
High-level mupirocin resistance in coagulase-negative staphylococci isolated from patients undergoing peritoneal dialysis was investigated by transfer of the resistance determinants, usually in the form of a plasmid, to Staphylococcus aureus strains, cleavage of the plasmid by restriction endonuclease and hybridisation with a probe comprising a 4.05 kb
Stuart Connolly, W. C. Noble, Ian Phillips   +2 more
openalex   +4 more sources

Phage typing of coagulase-negative staphylococci

Journal of Clinical Pharmacy and Therapeutics, 1992
Seventy-nine staphylococcal strains isolated from blood cultures (57 coagulase-negative staphylococci (CNS) and 22 S. aureus) and 308 CNS isolated from the skin of healthy donors were phage typed. S. epidermidis and S. capitis were readily typed with 91 strains out of 124 and 24 strains out of 43 strains being successful.
Paule Boussard, A. Pithsy, Michel Devleeschouwer, J Dony   +3 more
openalex   +4 more sources

Toxigenic Genes of Coagulase-negative Staphylococci and Staphylococcus aureus from Milk and Dairy

Journal of Agricultural Sciences, 2023
The study investigates the prevalence of Staphylococcus aureus and coagulasenegative staphylococci in raw milk and dairy products and assesses their toxin-related pathogenic potential and methicillin resistance.
Burcu Erten, Gül Ece Soyutemiz, Figen Çetinkaya, Tülay Elal Muş   +3 more
doaj   +1 more source

Antibiotic sensitivity analysis of clinical coagulase-negative staphylococci

Acta Biomedica Scientifica, 2022
Background. The increasing role of coagulase-negative staphylococci in the occurrence of staphylococcal infections leads to the need for close attention to them.
L. I. Kononova, L. M. Lemkina, V. P. Korobov   +2 more
doaj   +1 more source

Secondary infections worsen the outcome of COVID‐19 in patients with hematological malignancies: A report from the ITA‐HEMA‐COV

Hematological Oncology, Volume 40, Issue 5, Page 846-856, December 2022., 2022
Abstract The impact of secondary infections (SI) on COVID‐19 outcome in patients with hematological malignancies (HM) is scarcely documented. To evaluate incidence, clinical characteristics, and outcome of SI, we analyzed the microbiologically documented SI in a large multicenter cohort of adult HM patients with COVID‐19.
Patrizia Zappasodi, Chiara Cattaneo, Virginia Valeria Ferretti, Roberto Mina, Andrés José María Ferreri, Francesco Merli, Margherita Oberti, Mauro Krampera, Alessandra Romano, Caterina Zerbi, Jacqueline Ferrari, Michele Cavo, Marco Salvini, Lorenza Bertù, Nicola Stefano Fracchiolla, Francesco Marchesi, Massimo Massaia, Vincenzo Marasco, Roberto Cairoli, Anna Maria Scattolin, Alessandro Maria Vannucchi, Carlo Gambacorti‐Passerini, Pellegrino Musto, Filippo Gherlinzoni, Antonio Cuneo, Antonello Pinto, Livio Trentin, Monica Bocchia, Sara Galimberti, Elisa Coviello, Maria Chiara Tisi, Alessandro Morotti, Brunangelo Falini, Mauro Turrini, Agostino Tafuri, Atto Billio, Massimo Gentile, Roberto Massimo Lemoli, Adriano Venditti, Matteo Giovanni Della Porta, Francesco Lanza, Luigi Rigacci, Patrizia Tosi, Sara Mohamed, Alessandro Corso, Mario Luppi, Nicola Giuliani, Alessandro Busca, Livio Pagano, Raffaele Bruno, Paolo Antonio Grossi, Paolo Corradini, Francesco Passamonti, Luca Arcaini, on behalf of the ITA‐HEMA‐COV Investigators   +54 more
wiley   +1 more source